NO881501D0 - RECOMBINANT HTLV-111 PROTEINS AND THE USE OF THESE. - Google Patents

RECOMBINANT HTLV-111 PROTEINS AND THE USE OF THESE.

Info

Publication number
NO881501D0
NO881501D0 NO881501A NO881501A NO881501D0 NO 881501 D0 NO881501 D0 NO 881501D0 NO 881501 A NO881501 A NO 881501A NO 881501 A NO881501 A NO 881501A NO 881501 D0 NO881501 D0 NO 881501D0
Authority
NO
Norway
Prior art keywords
proteins
recombinant htlv
htlv
recombinant
Prior art date
Application number
NO881501A
Other languages
Norwegian (no)
Other versions
NO881501L (en
Inventor
Debra Lynn
Kashayar Javaberian
William Thomas Mueller
John Farley
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of NO881501D0 publication Critical patent/NO881501D0/en
Publication of NO881501L publication Critical patent/NO881501L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/21Retroviridae, e.g. equine infectious anemia virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO88881501A 1987-10-09 1988-04-07 RECOMBINANT HTLV-111 PROTEINS AND USES OF THESE. NO881501L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10723187A 1987-10-09 1987-10-09

Publications (2)

Publication Number Publication Date
NO881501D0 true NO881501D0 (en) 1988-04-07
NO881501L NO881501L (en) 1989-04-10

Family

ID=22315557

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88881501A NO881501L (en) 1987-10-09 1988-04-07 RECOMBINANT HTLV-111 PROTEINS AND USES OF THESE.

Country Status (6)

Country Link
JP (1) JPH01193228A (en)
KR (1) KR890006250A (en)
AU (1) AU613944B2 (en)
NO (1) NO881501L (en)
PT (1) PT87208A (en)
ZA (1) ZA883261B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171119B1 (en) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS virus envelope protein, expression vector carrying the envelope protein, transformants transformed with the expression vector, method of producing the virus envelope protein, method of detecting AIDS antibodies, method of determining AIDS virus, vaccine against AIDS, antibodies against the virus envelope protein and use of it to prepare a vaccine and for testing
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus

Also Published As

Publication number Publication date
PT87208A (en) 1989-07-31
JPH01193228A (en) 1989-08-03
NO881501L (en) 1989-04-10
AU2117288A (en) 1989-04-13
KR890006250A (en) 1989-06-12
ZA883261B (en) 1988-12-06
AU613944B2 (en) 1991-08-15

Similar Documents

Publication Publication Date Title
DE3788626D1 (en) Polypeptides containing Nor-Statin and Nor-Cyclostatin.
NO864590L (en) THE CRYOGEN AND ULTRASONIC SCALPELL.
DK299087D0 (en) PROTEINS AND DERIVATIVES THEREOF
DK47285D0 (en) PURE-INHIBITING PEPTIDES AND THEIR USE thereof
NO881658L (en) BIOFUNCTIONAL PROTEINS.
NO882226D0 (en) FIBRINOLYTIC PROTEINS.
NO882917D0 (en) FUSION PROTEINS AND PARTICLES.
DK353788A (en) Polypeptide
DK639988D0 (en) PEPTIDES AND USE THEREOF.
DK224985A (en) PEPTIDES, AND AGENTS CONTAINING THE PEPTIDES
NO873216L (en) RECOMBINANT HTLV-III PROTEINS AND USE THEREOF.
NO881502D0 (en) RECOMBINANT HTLV-111 PROTEINS AND THE USE OF THESE.
NO905561D0 (en) PROTEINS AND NUCLEIC ACIDS.
NO884324D0 (en) PROCEDURE FOR THE PREPARATION OF PURE-INHIBITING PEPTIDES AND THEIR USE.
NO881501D0 (en) RECOMBINANT HTLV-111 PROTEINS AND THE USE OF THESE.
DK604589A (en) PEPTIDES AND THE ANALYSIS OF CONTENT OF SUCH RELATIONS
NO864717D0 (en) CARBOXYL GROUPED POLYAMIDES AND PROCEDURES FOR THE PREPARATION OF THESE.
DK32689A (en) TEICOPLANINE HYDRAZIDES AND THE PREPARATION AND APPLICATION OF THEREOF
DK604689A (en) PEPTIDES AND THE ANALYSIS OF CONTENT OF SUCH RELATIONS
NO882836D0 (en) PROCEDURE FOR CHEMICAL MODIFICATION OF PROTIDES (PROTEINS AND PEPTIDES).
NO875086D0 (en) PROCEDURE FOR THE MANUFACTURING OF ORGANOTITANE MATERIALS AND THE USE OF THESE.
IS3300A7 (en) New polypeptides and their use.
NO912279D0 (en) PROCEDURE FOR THE PREPARATION AND USE OF EXPLOSION-SAFE 1-DIMETHYLAMINO-3-DIMETYLIMINO-2-ARYLPROP-1-EN-SALTER.
IS3269A7 (en) New peptides and their use
NO904846D0 (en) AMFIFILE PEPTIDES AND USE THEREOF.